Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jo Van Damme

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Genes & Molecular Sequences

Amino Acid Sequence

Concepts & Ideas

Molecular Sequence Data

Chemicals & Drugs

Physiology

Leukocyte Chemotaxis

Living Beings

Mice

Anatomy

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
108
Proost, Paul
95
Opdenakker, Ghislain
68
Struyf, Sofie
50
Billiau, An
43
Wuyts, Anja
30
Lenaerts, Jean-Pierre
28
Put, Willy
23
Conings, René
22
Schutyser, Evemie
20
Menten, Patricia
19
Gouwy, Mieke
16
Dillen, Chris
16
Geboes, Karel
16
Van den Steen, Philippe
15
Heremans, Hubertine

Sign-in to see all Coauthors

Publications

TOP 3
Sliepen I; Van Damme J; Van Essche M; Loozen G; Quirynen M; Teughels W
Microbial interactions influence inflammatory host cell responses.
Loos Tamara; Opdenakker Ghislain; Van Damme Jo; Proost Paul
Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation.
Gouwy Mieke; Struyf Sofie; Verbeke Hannelien; Put Willy; Proost Paul; Opdenakker Ghislain; Van Damme Jo
CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jo Van Damme (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Sliepen I; Van Damme J; Van Essche M; Loozen G; Quirynen M; Teughels W
Microbial interactions influence inflammatory host cell responses.
Journal of dental research 2009;88(11):1026-30.
2009: Loos Tamara; Opdenakker Ghislain; Van Damme Jo; Proost Paul
Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation.
Haematologica 2009;94(10):1346-53.
2009: Gouwy Mieke; Struyf Sofie; Verbeke Hannelien; Put Willy; Proost Paul; Opdenakker Ghislain; Van Damme Jo
CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8.
Journal of leukocyte biology 2009;86(3):671-80.
2009: Michiels Katleen; Schutyser Evemie; Conings René; Lenaerts Jean-Pierre; Put Willy; Nuyts Sandra; Delaere Pierre; Jacobs Reinhilde; Struyf Sofie; Proost Paul; Van Damme Jo
Carcinoma cell-derived chemokines and their presence in oral fluid.
European journal of oral sciences 2009;117(4):362-8.
2009: Piccard Helene; Hu Jialiang; Fiten Pierre; Proost Paul; Martens Erik; Van den Steen Philippe E; Van Damme Jo; Opdenakker Ghislain
"Reverse degradomics", monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products.
Electrophoresis 2009;30(13):2366-77.
2009: Struyf Sofie; Proost Paul; Vandercappellen Jo; Dempe Sebastian; Noyens Becky; Nelissen Sofie; Gouwy Mieke; Locati Massimo; Opdenakker Ghislain; Dinsart Christiane; Van Damme Jo
Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects.
European journal of immunology 2009;39(3):843-57.
2009: Struyf Sofie; Noppen Samuel; Loos Tamara; Mortier Anneleen; Gouwy Mieke; Verbeke Hannelien; Huskens Dana; Luangsay Souphalone; Parmentier Marc; Geboes Karel; Schols Dominique; Van Damme Jo; Proost Paul
Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(1):666-74.
2009: Kelchtermans Hilde; Schurgers Evelien; Geboes Lies; Mitera Tania; Van Damme Jo; Van Snick Jacques; Uyttenhove Catherine; Matthys Patrick
Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma.
Arthritis research & therapy 2009;11(4):R122.
2009: Qiu Zheng; Dillen Chris; Hu Jialiang; Verbeke Hannelien; Struyf Sofie; Van Damme Jo; Opdenakker Ghislain
Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes.
Immunobiology 2009;214(9-10):835-42.
2008: Mortier Anneleen; Van Damme Jo; Proost Paul
Regulation of chemokine activity by posttranslational modification.
Pharmacology & therapeutics 2008;120(2):197-217.
2008: Loos Tamara; Mortier Anneleen; Gouwy Mieke; Ronsse Isabelle; Put Willy; Lenaerts Jean-Pierre; Van Damme Jo; Proost Paul
Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Blood 2008;112(7):2648-56.
2008: Proost Paul; Loos Tamara; Mortier Anneleen; Schutyser Evemie; Gouwy Mieke; Noppen Samuel; Dillen Chris; Ronsse Isabelle; Conings René; Struyf Sofie; Opdenakker Ghislain; Maudgal Prabhat C; Van Damme Jo
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.
The Journal of experimental medicine 2008;205(9):2085-97.
2008: Vandercappellen Jo; Van Damme Jo; Struyf Sofie
The role of CXC chemokines and their receptors in cancer.
Cancer letters 2008;267(2):226-44.
2008: Gouwy Mieke; Struyf Sofie; Noppen Samuel; Schutyser Evemie; Springael Jean-Yves; Parmentier Marc; Proost Paul; Van Damme Jo
Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events.
Molecular pharmacology 2008;74(2):485-95.
2008: Abu El-Asrar A M; Struyf S; Van Damme J; Geboes K
Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes.
The British journal of ophthalmology 2008;92(5):699-704.
2007: Vandercappellen Jo; Noppen Samuel; Verbeke Hannelien; Put Willy; Conings René; Gouwy Mieke; Schutyser Evemie; Proost Paul; Sciot Raf; Geboes Karel; Opdenakker Ghislain; Van Damme Jo; Struyf Sofie
Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.
Journal of leukocyte biology 2007;82(6):1519-30.
2007: Abu El-Asrar Ahmed M; Struyf Sofie; Opdenakker Ghislain; Geboes Karel; Van Damme Jo
The role of chemokines and their receptors in uveitis.
International ophthalmology 2007;27(5):321-7.
2007: Proost Paul; Mortier Anneleen; Loos Tamara; Vandercappellen Jo; Gouwy Mieke; Ronsse Isabelle; Schutyser Evemie; Put Willy; Parmentier Marc; Struyf Sofie; Van Damme Jo
Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.
Blood 2007;110(1):37-44.
2007: Schutyser Evemie; Su Yingjun; Yu Yingchun; Gouwy Mieke; Zaja-Milatovic Snjezana; Van Damme Jo; Richmond Ann
Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.
European cytokine network 2007;18(2):59-70.
2007: Struyf Sofie; Burdick Marie D; Peeters Elke; Van den Broeck Karolien; Dillen Chris; Proost Paul; Van Damme Jo; Strieter Robert M
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.
Cancer research 2007;67(12):5940-8.
2007: Kelchtermans Hilde; Struyf Sofie; De Klerck Bert; Mitera Tania; Alen Marijke; Geboes Lies; Van Balen Maarten; Dillen Chris; Put Willy; Gysemans Conny; Billiau Alfons; Van Damme Jo; Matthys Patrick
Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production.
Journal of leukocyte biology 2007;81(4):1044-53.
2007: Martens Erik; Leyssen An; Van Aelst Ilse; Fiten Pierre; Piccard Helene; Hu Jialiang; Descamps Francis J; Van den Steen Philippe E; Proost Paul; Van Damme Jo; Liuzzi Grazia Maria; Riccio Paolo; Polverini Eugenia; Opdenakker Ghislain
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains.
Biochimica et biophysica acta 2007;1770(2):178-86.
2006: Abu El-Asrar Ahmed M; Struyf Sofie; Kangave Dustan; Geboes Karel; Van Damme Jo
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
European cytokine network 2006;17(3):155-65.
2006: Loos Tamara; Dekeyzer Lies; Struyf Sofie; Schutyser Evemie; Gijsbers Klara; Gouwy Mieke; Fraeyman Annelies; Put Willy; Ronsse Isabelle; Grillet Bernard; Opdenakker Ghislain; Van Damme Jo; Proost Paul
TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis.
Laboratory investigation; a journal of technical methods and pathology 2006;86(9):902-16.
2006: Descamps Francis J; Martens Erik; Kangave Dustan; Struyf Sofie; Geboes Karel; Van Damme Jo; Opdenakker Ghislain; Abu El-Asrar Ahmed M
The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage.
Experimental eye research 2006;83(2):401-7.
2006: Opdenakker Ghislain; Dillen Chris; Fiten Pierre; Martens Erik; Van Aelst Ilse; Van den Steen Philippe E; Nelissen Inge; Starckx Sofie; Descamps Francis J; Hu Jialiang; Piccard Helene; Van Damme Jo; Wormald Mark R; Rudd Pauline M; Dwek Raymond A
Remnant epitopes, autoimmunity and glycosylation.
Biochimica et biophysica acta 2006;1760(4):610-5.
2006: Gijsbers K; Geboes K; Van Damme J
Chemokines in gastrointestinal disorders.
Current drug targets 2006;7(1):47-64.
2006: Proost Paul; Struyf Sofie; Loos Tamara; Gouwy Mieke; Schutyser Evemie; Conings René; Ronsse Isabelle; Parmentier Marc; Grillet Bernard; Opdenakker Ghislain; Balzarini Jan; Van Damme Jo
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies.
Arthritis research & therapy 2006;8(4):R107.
2005: Gouwy Mieke; Struyf Sofie; Proost Paul; Van Damme Jo
Synergy in cytokine and chemokine networks amplifies the inflammatory response.
Cytokine & growth factor reviews 2005;16(6):561-80.
2005: Schutyser Evemie; Richmond Ann; Van Damme Jo
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.
Journal of leukocyte biology 2005;78(1):14-26.
2005: Struyf Sofie; Gouwy Mieke; Dillen Chris; Proost Paul; Opdenakker Ghislain; Van Damme Jo
Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue.
European journal of immunology 2005;35(5):1583-91.
2005: Gijsbers Klara; Gouwy Mieke; Struyf Sofie; Wuyts Anja; Proost Paul; Opdenakker Ghislain; Penninckx Freddy; Ectors Nadine; Geboes Karel; Van Damme Jo
GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors.
Experimental cell research 2005;303(2):331-42.
2005: Descamps Francis J; Martens Erik; Proost Paul; Starckx Sofie; Van den Steen Philippe E; Van Damme Jo; Opdenakker Ghislain
Gelatinase B/matrix metalloproteinase-9 provokes cataract by cleaving lens betaB1 crystallin.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(1):29-35.
2004: Catusse Julie; Struyf Sofie; Wuyts Anja; Weyler Myke; Loos Tamara; Gijsbers Klara; Gouwy Mieke; Proost Paul; Van Damme Jo
Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
Biochemical pharmacology 2004;68(10):1947-55.
2004: Struyf Sofie; Burdick Marie D; Proost Paul; Van Damme Jo; Strieter Robert M
Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis.
Circulation research 2004;95(9):855-7.
2004: Abu El-Asrar Ahmed M; Struyf Sofie; Descamps Francis J; Al-Obeidan Saleh A; Proost Paul; Van Damme Jo; Opdenakker Ghislain; Geboes Karel
Chemokines and gelatinases in the aqueous humor of patients with active uveitis.
American journal of ophthalmology 2004;138(3):401-11.
2004: Balzarini Jan; Andersson Elin; Schols Dominique; Proost Paul; Van Damme Jo; Svennerholm Bo; Horal Peter; Vahlne Anders
Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
The international journal of biochemistry & cell biology 2004;36(9):1848-59.
2004: Van den Steen P E; Proost P; Brand D D; Kang A H; Van Damme J; Opdenakker G
Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.
Biochemistry 2004;43(33):10809-16.
2004: Gijsbers Klara; Van Assche Gert; Joossens Sofie; Struyf Sofie; Proost Paul; Rutgeerts Paul; Geboes Karel; Van Damme Jo
CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue.
European journal of immunology 2004;34(7):1992-2000.
2004: Gouwy Mieke; Struyf Sofie; Catusse Julie; Proost Paul; Van Damme Jo
Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration.
Journal of leukocyte biology 2004;76(1):185-94.
2004: Van Damme Jo; Struyf Sofie; Opdenakker Ghislain
Chemokine-protease interactions in cancer.
Seminars in cancer biology 2004;14(3):201-8.
2004: Proost Paul; Verpoest Sara; Van de Borne Kirsten; Schutyser Evemie; Struyf Sofie; Put Willy; Ronsse Isabelle; Grillet Bernard; Opdenakker Ghislain; Van Damme Jo
Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Journal of leukocyte biology 2004;75(5):777-84.
2004: Opdenakker Ghislain; Van Damme Jo
The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.
The International journal of developmental biology 2004;48(5-6):519-27.
2004: Proost Paul; Mahieu Frank; Schutyser Evemie; Van Damme Jo
Posttranslational processing of chemokines.
Methods in molecular biology (Clifton, N.J.) 2004;239():27-44.
2004: Wuyts Anja; Menten Patricia; Van Osselaer Nancy; Van Damme Jo
Assays for chemotaxis.
Methods in molecular biology (Clifton, N.J.) 2004;249():153-66.
2004: Menten Patricia; Wuyts Anja; Van Damme Jo
Purification, identification, and synthesis of chemokines.
Methods in molecular biology (Clifton, N.J.) 2004;249():47-64.
2003: Opdenakker Ghislain; Nelissen Inge; Van Damme Jo
Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis.
Lancet neurology 2003;2(12):747-56.
2003: Abu El-Asrar Ahmed M; Struyf Sofie; Al-Kharashi Soliman A; Missotten Luc; Van Damme Jo; Geboes Karel
The T-lymphocyte chemoattractant Mig is highly expressed in vernal keratoconjunctivitis.
American journal of ophthalmology 2003;136(5):853-60.
2003: Proost Paul; Vynckier An-Katrien; Mahieu Frank; Put Willy; Grillet Bernard; Struyf Sofie; Wuyts Anja; Opdenakker Ghislain; Van Damme Jo
Microbial Toll-like receptor ligands differentially regulate CXCL10/IP-10 expression in fibroblasts and mononuclear leukocytes in synergy with IFN-gamma and provide a mechanism for enhanced synovial chemokine levels in septic arthritis.
European journal of immunology 2003;33(11):3146-53.
2003: Struyf Sofie; Schutyser Evemie; Gouwy Mieke; Gijsbers Klara; Proost Paul; Benoit Yves; Opdenakker Ghislain; Van Damme Jo; Laureys Geneviève
PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.
The American journal of pathology 2003;163(5):2065-75.
2003: Van den Steen Philippe E; Husson Steven J; Proost Paul; Van Damme Jo; Opdenakker Ghislain
Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase.
Biochemical and biophysical research communications 2003;310(3):889-96.
2003: Schutyser Evemie; Struyf Sofie; Van Damme Jo
The CC chemokine CCL20 and its receptor CCR6.
Cytokine & growth factor reviews 2003;14(5):409-26.
2003: Van Den Steen Philippe E; Wuyts Anja; Husson Steven J; Proost Paul; Van Damme Jo; Opdenakker Ghislain
Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.
European journal of biochemistry / FEBS 2003;270(18):3739-49.
2003: Le Poul Emmanuel; Loison Cecile; Struyf Sofie; Springael Jean-Yves; Lannoy Vincent; Decobecq Marie-Eve; Brezillon Stephane; Dupriez Vincent; Vassart Gilbert; Van Damme Jo; Parmentier Marc; Detheux Michel
Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.
The Journal of biological chemistry 2003;278(28):25481-9.
2003: Wuyts Anja; Struyf Sofie; Gijsbers Klara; Schutyser Evemie; Put Willy; Conings René; Lenaerts Jean-Pierre; Geboes Karel; Opdenakker Ghislain; Menten Patricia; Proost Paul; Van Damme Jo
The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8.
Laboratory investigation; a journal of technical methods and pathology 2003;83(1):23-34.
2003: Descamps Francis J; Van den Steen Philippe E; Nelissen Inge; Van Damme Jo; Opdenakker Ghislain
Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes.
Advances in experimental medicine and biology 2003;535():69-77.
2003: Struyf Sofie; Proost Paul; Van Damme Jo
Regulation of the immune response by the interaction of chemokines and proteases.
Advances in immunology 2003;81():1-44.
2002: Menten Patricia; Wuyts Anja; Van Damme Jo
Macrophage inflammatory protein-1.
Cytokine & growth factor reviews 2002;13(6):455-81.
2002: Van den Bergh Karolien P B; Proost Paul; Van Damme Jo; Coosemans Jozef; Van Damme Els J M; Peumans Willy J
Five disulfide bridges stabilize a hevein-type antimicrobial peptide from the bark of spindle tree (Euonymus europaeus L.).
FEBS letters 2002;530(1-3):181-5.
2002: Menten Patricia; Saccani Alessandra; Dillen Chris; Wuyts Anja; Struyf Sofie; Proost Paul; Mantovani Alberto; Wang Ji Ming; Van Damme Jo
Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma.
Journal of leukocyte biology 2002;72(4):780-9.
2002: El-Asrar A M Abu; Struyf S; Al-Kharashi S A; Missotten L; Van Damme J; Geboes K
Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis.
The British journal of ophthalmology 2002;86(10):1175-80.
2002: Starckx Sofie; Wuyts Anja; Opsomer Inge; Van Coillie Els; Proost Paul; Arnold Bernd; Van Damme Jo; Opdenakker Ghislain
Recombinant mouse granulocyte chemotactic protein-2: production in bacteria, characterization, and systemic effects on leukocytes.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(9):965-74.
2002: Gouwy Mieke; Struyf Sofie; Mahieu Frank; Put Willy; Proost Paul; Van Damme Jo
The unique property of the CC chemokine regakine-1 to synergize with other plasma-derived inflammatory mediators in neutrophil chemotaxis does not reside in its NH2-terminal structure.
Molecular pharmacology 2002;62(1):173-80.
2002: Schutyser Evemie; Struyf Sofie; Proost Paul; Opdenakker Ghislain; Laureys Genevieve; Verhasselt Bruno; Peperstraete Lieven; Van de Putte Ignace; Saccani Alessandra; Allavena Paola; Mantovani Alberto; Van Damme Jo
Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma.
The Journal of biological chemistry 2002;277(27):24584-93.
2002: Van den Steen Philippe E; Proost Paul; Grillet Bernard; Brand David D; Kang Andrew H; Van Damme Jo; Opdenakker Ghislain
Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(3):379-89.
2002: Starckx S; Van den Steen P E; Wuyts A; Van Damme J; Opdenakker G
Neutrophil gelatinase B and chemokines in leukocytosis and stem cell mobilization.
Leukemia & lymphoma 2002;43(2):233-41.
2002: Nelissen Inge; Ronsse Isabelle; Van Damme Jo; Opdenakker Ghislain
Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta.
Journal of leukocyte biology 2002;71(1):89-98.
2001: Schutyser E; Struyf S; Wuyts A; Put W; Geboes K; Grillet B; Opdenakker G; Van Damme J
Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis.
European journal of immunology 2001;31(12):3755-62.
2001: Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir A M; Neyts J; Liekens S; Maudgal P C; Billiau A; Van Damme J
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Blood 2001;98(13):3554-61.
2001: Lambeir A M; Durinx C; Proost P; Van Damme J; Scharpé S; De Meester I
Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion.
FEBS letters 2001;507(3):327-30.
2001: Abu El-Asrar A M; Struyf S; Al-Mosallam A A; Missotten L; Van Damme J; Geboes K
Expression of chemokine receptors in vernal keratoconjunctivitis.
The British journal of ophthalmology 2001;85(11):1357-61.
2001: Menten P; Wuyts A; Van Damme J
Monocyte chemotactic protein-3.
European cytokine network 2001;12(4):554-60.
2001: Van Coillie E; Van Aelst I; Wuyts A; Vercauteren R; Devos R; De Wolf-Peeters C; Van Damme J; Opdenakker G
Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle.
The American journal of pathology 2001;159(4):1405-14.
2001: Struyf S; Stoops G; Van Coillie E; Gouwy M; Schutyser E; Lenaerts J P; Fiten P; Van Aelst I; Proost P; Opdenakker G; Van Damme J
Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants.
Biochemistry 2001;40(39):11715-22.
2001: Lambeir A M; Proost P; Durinx C; Bal G; Senten K; Augustyns K; Scharpé S; Van Damme J; De Meester I
Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family.
The Journal of biological chemistry 2001;276(32):29839-45.
2001: Struyf S; Menten P; Lenaerts J P; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
European journal of immunology 2001;31(7):2170-8.
2001: Opdenakker G; Van den Steen P E; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
Gelatinase B functions as regulator and effector in leukocyte biology.
Journal of leukocyte biology 2001;69(6):851-9.
2001: Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Journal of virology 2001;75(9):4402-6.
2001: Struyf S; Proost P; Lenaerts J P; Stoops G; Wuyts A; Van Damme J
Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1.
Blood 2001;97(8):2197-204.
2000: Mattu T S; Royle L; Langridge J; Wormald M R; Van den Steen P E; Van Damme J; Opdenakker G; Harvey D J; Dwek R A; Rudd P M
O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme.
Biochemistry 2000;39(51):15695-704.
2000: Abu El-Asrar A M; Struyf S; Al-Kharashi S A; Missotten L; Van Damme J; Geboes K
Chemokines in the limbal form of vernal keratoconjunctivitis.
The British journal of ophthalmology 2000;84(12):1360-6.
2000: Wuyts A; Schutyser E; Menten P; Struyf S; D'Haese A; Bult H; Opdenakker G; Proost P; Van Damme J
Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages.
Biochemistry 2000;39(47):14549-57.
2000: Schutyser E; Struyf S; Menten P; Lenaerts J P; Conings R; Put W; Wuyts A; Proost P; Van Damme J
Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(8):4470-7.
2000: Van den Steen P E; Proost P; Wuyts A; Van Damme J; Opdenakker G
Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.
Blood 2000;96(8):2673-81.
2000: Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Blood 2000;96(5):1674-80.
2000: D'Haese A; Wuyts A; Dillen C; Dubois B; Billiau A; Heremans H; Van Damme J; Arnold B; Opdenakker G
In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2000;20(7):667-74.
2000: Sica A; Saccani A; Bottazzi B; Polentarutti N; Vecchi A; van Damme J; Mantovani A
Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):762-7.
1999: Wuyts A; D'Haese A; Cremers V; Menten P; Lenaerts J P; De Loof A; Heremans H; Proost P; Van Damme J
NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(11):6155-63.
1999: Rudd P M; Mattu T S; Masure S; Bratt T; Van den Steen P E; Wormald M R; Küster B; Harvey D J; Borregaard N; Van Damme J; Dwek R A; Opdenakker G
Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin.
Biochemistry 1999;38(42):13937-50.
1999: Pype J L; Dupont L J; Menten P; Van Coillie E; Opdenakker G; Van Damme J; Chung K F; Demedts M G; Verleden G M
Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines.
American journal of respiratory cell and molecular biology 1999;21(4):528-36.
1999: Van Coillie E; Van Aelst I; Fiten P; Billiau A; Van Damme J; Opdenakker G
Transcriptional control of the human MCP-2 gene promoter by IFN-gamma and IL-1beta in connective tissue cells.
Journal of leukocyte biology 1999;66(3):502-11.
1999: Menten P; Struyf S; Schutyser E; Wuyts A; De Clercq E; Schols D; Proost P; Van Damme J
The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
The Journal of clinical investigation 1999;104(4):R1-5.
1999: Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts J P; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4903-9.
1999: Van Coillie E; Van Damme J; Opdenakker G
The MCP/eotaxin subfamily of CC chemokines.
Cytokine & growth factor reviews 1999;10(1):61-86.
1999: Fiten P; Vandenbroeck K; Dubois B; Van Coillie E; Nelissen I; Van Damme J; Ligers A; Hillert J; Andersson M; Olsson T; Opdenakker G
Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development.
Journal of neuroimmunology 1999;95(1-2):195-201.
1999: Wuyts A; Govaerts C; Struyf S; Lenaerts J P; Put W; Conings R; Proost P; Van Damme J
Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms.
European journal of biochemistry / FEBS 1999;260(2):421-9.
1999: Menten P; Proost P; Struyf S; Van Coillie E; Put W; Lenaerts J P; Conings R; Jaspar J M; De Groote D; Billiau A; Opdenakker G; Van Damme J
Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity.
European journal of immunology 1999;29(2):678-85.
1999: Proost P; Struyf S; Schols D; Opdenakker G; Sozzani S; Allavena P; Mantovani A; Augustyns K; Bal G; Haemers A; Lambeir A M; Scharpé S; Van Damme J; De Meester I
Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.
The Journal of biological chemistry 1999;274(7):3988-93.
1999: Van Damme J; Struyf S; Wuyts A; Van Coillie E; Menten P; Schols D; Sozzani S; De Meester I; Proost P
The role of CD26/DPP IV in chemokine processing.
Chemical immunology 1999;72():42-56.
1998: Van den Steen P; Rudd P M; Proost P; Martens E; Paemen L; Küster B; van Damme J; Dwek R A; Opdenakker G
Oligosaccharides of recombinant mouse gelatinase B variants.
Biochimica et biophysica acta 1998;1425(3):587-98.
1998: Proost P; Struyf S; Wuyts A; Menten P; De Meester I; Lambeir A M; Scharpé S; Schols D; De Clercq E; Van Damme J
Isolation and identification of naturally modified C-C chemokines MCP-1, MCP-2 and RANTES: effects of posttranslational modifications on receptor usage, chemotactic and anti-HIV-1 activity.
European cytokine network 1998;9(3 Suppl):73-5.
1998: Struyf S; Proost P; Sozzani S; Mantovani A; Wuyts A; De Clercq E; Schols D; Van Damme J
Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(6):2672-5.
1998: Van Coillie E; Proost P; Van Aelst I; Struyf S; Polfliet M; De Meester I; Harvey D J; Van Damme J; Opdenakker G
Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
Biochemistry 1998;37(36):12672-80.
1998: Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts J P; De Clercq E; De Meester I; Van Damme J
Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
FEBS letters 1998;432(1-2):73-6.
1998: Wuyts A; Proost P; Lenaerts J P; Ben-Baruch A; Van Damme J; Wang J M
Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
European journal of biochemistry / FEBS 1998;255(1):67-73.
1998: Dubois B; Peumans W J; Van Damme E J; Van Damme J; Opdenakker G
Regulation of gelatinase B (MMP-9) in leukocytes by plant lectins.
FEBS letters 1998;427(2):275-8.
1998: Opdenakker G; Fibbe W E; Van Damme J
The molecular basis of leukocytosis.
Immunology today 1998;19(4):182-9.
1998: Struyf S; De Meester I; Scharpé S; Lenaerts J P; Menten P; Wang J M; Proost P; Van Damme J
Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor.
European journal of immunology 1998;28(4):1262-71.
1998: Proost P; Struyf S; Couvreur M; Lenaerts J P; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J
Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(8):4034-41.
1998: Proost P; De Meester I; Schols D; Struyf S; Lambeir A M; Wuyts A; Opdenakker G; De Clercq E; Scharpé S; Van Damme J
Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.
The Journal of biological chemistry 1998;273(13):7222-7.
1998: Struyf S; Van Collie E; Paemen L; Put W; Lenaerts J P; Proost P; Opdenakker G; Van Damme J
Synergistic induction of MCP-1 and -2 by IL-1beta and interferons in fibroblasts and epithelial cells.
Journal of leukocyte biology 1998;63(3):364-72.
1998: Van den Steen P; Rudd P M; Dwek R A; Van Damme J; Opdenakker G
Cytokine and protease glycosylation as a regulatory mechanism in inflammation and autoimmunity.
Advances in experimental medicine and biology 1998;435():133-43.
1997: Van Damme J; Wuyts A; Froyen G; Van Coillie E; Struyf S; Billiau A; Proost P; Wang J M; Opdenakker G
Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage.
Journal of leukocyte biology 1997;62(5):563-9.
1997: Schols D; Proost P; Van Damme J; De Clercq E
RANTES and MCP-3 inhibit the replication of T-cell-tropic human immunodeficiency virus type 1 strains (SF-2, MN, and HE).
Journal of virology 1997;71(10):7300-4.
1997: Paemen L; Jansen P M; Proost P; Van Damme J; Opdenakker G; Hack E; Taylor F B
Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia.
Cytokine 1997;9(6):412-5.
1997: Abu el-Asrar A M; Van Damme J; Put W; Veckeneer M; Dralands L; Billiau A; Missotten L
Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
American journal of ophthalmology 1997;123(5):599-606.
1997: Van Coillie E; Fiten P; Nomiyama H; Sakaki Y; Miura R; Yoshie O; Van Damme J; Opdenakker G
The human MCP-2 gene (SCYA8): cloning, sequence analysis, tissue expression, and assignment to the CC chemokine gene contig on chromosome 17q11.2.
Genomics 1997;40(2):323-31.
1997: Wuyts A; Van Osselaer N; Haelens A; Samson I; Herdewijn P; Ben-Baruch A; Oppenheim J J; Proost P; Van Damme J
Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties.
Biochemistry 1997;36(9):2716-23.
1997: Van Coillie E; Froyen G; Nomiyama H; Miura R; Fiten P; Van Aelst I; Van Damme J; Opdenakker G
Human monocyte chemotactic protein-2: cDNA cloning and regulated expression of mRNA in mesenchymal cells.
Biochemical and biophysical research communications 1997;231(3):726-30.
1997: Masure S; Paemen L; Van Aelst I; Fiten P; Proost P; Billiau A; Van Damme J; Opdenakker G
Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration.
European journal of biochemistry / FEBS 1997;244(1):21-30.
1997: Froyen G; Proost P; Ronsse I; Mitera T; Haelens A; Wuyts A; Opdenakker G; Van Damme J; Billiau A
Cloning, bacterial expression and biological characterization of recombinant human granulocyte chemotactic protein-2 and differential expression of granulocyte chemotactic protein-2 and epithelial cell-derived neutrophil activating peptide-78 mRNAs.
European journal of biochemistry / FEBS 1997;243(3):762-9.
1997: Van Damme J; Struyf S; Wuyts A; Opdenakker G; Proost P; Allavena P; Sozzani S; Mantovani A
Isolation of human monocyte chemotactic proteins and study of their producer and responder cells by immunotests and bioassays.
Methods in enzymology 1997;287():109-27.
1997: Wuyts A; Proost P; Froyen G; Haelens A; Billiau A; Opdenakker G; Van Damme J
Purification and identification of human and mouse granulocyte chemotactic protein-2 isoforms.
Methods in enzymology 1997;287():13-33.
1996: Haelens A; Wuyts A; Proost P; Struyf S; Opdenakker G; van Damme J
Leukocyte migration and activation by murine chemokines.
Immunobiology 1996;195(4-5):499-521.
1996: Liu Z G; Haelens A; Wuyts A; Struyf S; Pang X W; Proost P; Chen W F; van Damme J
Isolation of a lymphocyte chemotactic factor produced by the murine thymic epithelial cell line MTEC1: identification as a 30 kDa glycosylated form of MCP-1.
European cytokine network 1996;7(3):381-8.
1996: Wuyts A; Haelens A; Proost P; Lenaerts J P; Conings R; Opdenakker G; Van Damme J
Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(4):1736-43.
1996: Hoeben E; Van Damme J; Put W; Swinnen J V; Verhoeven G
Cytokines derived from activated human mononuclear cells markedly stimulate transferrin secretion by cultured Sertoli cells.
Endocrinology 1996;137(2):514-21.
1996: Proost P; Wuyts A; Van Damme J
Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1.
Journal of leukocyte biology 1996;59(1):67-74.
1996: Spittaels K; Vankeerberghen A; Schoofs L; Proost P; Van Damme J; De Loof A
Isolation and characterization of Locusta migratoria accessory gland myotropin I (Lom-Ag-MT-I) from the brain of the Colorado potato beetle, Leptinotarsa decemlineata.
Archives of insect biochemistry and physiology 1996;31(2):149-55.
1995: Norga K; Paemen L; Masure S; Dillen C; Heremans H; Billiau A; Carton H; Cuzner L; Olsson T; Van Damme J
Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1995;44(12):529-34.
1995: Masure S; Paemen L; Proost P; Van Damme J; Opdenakker G
Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP-3 receptor antagonist.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(11):955-63.
1995: Matthys P; Froyen G; Verdot L; Huang S; Sobis H; Van Damme J; Vray B; Aguet M; Billiau A
IFN-gamma receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(8):3823-9.
1995: Veelaert D; Schoofs L; Proost P; Van Damme J; Devreese B; Van Beeumen J; De Loof A
Isolation and identification of Lom-SG-SASP, a salivation stimulating peptide from the salivary glands of Locusta migratoria.
Regulatory peptides 1995;57(3):221-6.
1995: Matthys P; Mitera T; Heremans H; Van Damme J; Billiau A
Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.
Infection and immunity 1995;63(4):1158-64.
1995: Bylemans D; Proost P; Samijn B; Borovsky D; Grauwels L; Huybrechts R; Van Damme J; Van Beeumen J; De Loof A
Neb-colloostatin, a second folliculostatin of the grey fleshfly, Neobellieria bullata.
European journal of biochemistry / FEBS 1995;228(1):45-9.
1995: Proost P; Van Leuven P; Wuyts A; Ebberink R; Opdenakker G; Van Damme J
Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines.
Cytokine 1995;7(2):97-104.
1994: Van Mellaert L; Dillen C; Proost P; Sablon E; DeLeys R; Van Broekhoven A; Heremans H; Van Damme J; Eyssen H; Anné J
Efficient secretion of biologically active mouse tumor necrosis factor alpha by Streptomyces lividans.
Gene 1994;150(1):153-8.
1994: Proost P; Wuyts A; Lenaerts J P; Van Damme J
Purification, sequence analysis, and biological characterization of a second bovine monocyte chemotactic protein-1 (Bo MCP-1B).
Biochemistry 1994;33(45):13406-12.
1994: Wuyts A; Proost P; Put W; Lenaerts J P; Paemen L; van Damme J
Leukocyte recruitment by monocyte chemotactic proteins (MCPs) secreted by human phagocytes.
Journal of immunological methods 1994;174(1-2):237-47.
1994: Van Damme J; Proost P; Put W; Arens S; Lenaerts J P; Conings R; Opdenakker G; Heremans H; Billiau A
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(11):5495-502.
1994: Thirion S; Nys G; Fiten P; Masure S; Van Damme J; Opdenakker G
Mouse macrophage derived monocyte chemotactic protein-3: cDNA cloning and identification as MARC/FIC.
Biochemical and biophysical research communications 1994;201(2):493-9.
1994: Heremans H; Dillen C; van Damme J; Billiau A
Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice.
European journal of immunology 1994;24(5):1155-60.
1994: Opdenakker G; Fiten P; Nys G; Froyen G; Van Roy N; Speleman F; Laureys G; Van Damme J
The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12.
Genomics 1994;21(2):403-8.
1994: Van Damme J M; Smeets K; Torrekens S; Van Leuven F; Peumans W J
Characterization and molecular cloning of mannose-binding lectins from the Orchidaceae species Listera ovata, Epipactis helleborine and Cymbidium hybrid.
European journal of biochemistry / FEBS 1994;221(2):769-77.
1994: Tilemans D; Jacobs G F; Andries M; Proost P; Devreese B; Van Damme J; Van Beeumen J; Denef C
Isolation of two peptides from rat gonadotroph-conditioned medium displaying an amino acid sequence identical to fragments of secretogranin II.
Peptides 1994;15(3):537-45.
1993: Masure S; Nys G; Fiten P; Van Damme J; Opdenakker G
Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation.
European journal of biochemistry / FEBS 1993;218(1):129-41.
1993: Vandenbroeck K; Fiten P; Beuken E; Martens E; Janssen A; Van Damme J; Opdenakker G; Billiau A
Gene sequence, cDNA construction, expression in Escherichia coli and genetically approached purification of porcine interleukin-1 beta.
European journal of biochemistry / FEBS 1993;217(1):45-52.
1993: Van Damme J M; Smeets K; Torrekens S; Van Leuven F; Peumans W J
The mannose-specific lectins from ramsons (Allium ursinum L.) are encoded by three sets of genes.
European journal of biochemistry / FEBS 1993;217(1):123-9.
1993: Jorens P G; De Jongh R; De Backer W; Van Damme J; Van Overveld F; Bossaert L; Walter P; Herman A G; Rampart M
Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone.
The American review of respiratory disease 1993;148(4 Pt 1):890-5.
1993: Proost P; Wuyts A; Conings R; Lenaerts J P; Billiau A; Opdenakker G; Van Damme J
Human and bovine granulocyte chemotactic protein-2: complete amino acid sequence and functional characterization as chemokines.
Biochemistry 1993;32(38):10170-7.
1993: Matthys P; Dillen C; Proost P; Heremans H; Van Damme J; Billiau A
Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels.
European journal of immunology 1993;23(9):2209-16.
1993: Martens E; Dillen C; Put W; Heremans H; van Damme J; Billiau A
Increased circulating interleukin-6 (IL-6) activity in endotoxin-challenged mice pretreated with anti-IL-6 antibody is due to IL-6 accumulated in antigen-antibody complexes.
European journal of immunology 1993;23(8):2026-9.
1993: Schoofs L; Holman G M; Proost P; Van Damme J; Neven H; Oudejans R C; De Loof A
Isolation, identification, and synthesis of AKH-I4-10 from Locusta migratoria.
General and comparative endocrinology 1993;90(3):364-71.
1993: Proost P; Van Damme J; Opdenakker G
Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein.
Biochemical and biophysical research communications 1993;192(3):1175-81.
1993: Opdenakker G; Froyen G; Fiten P; Proost P; Van Damme J
Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines.
Biochemical and biophysical research communications 1993;191(2):535-42.
1993: Proost P; De Wolf-Peeters C; Conings R; Opdenakker G; Billiau A; Van Damme J
Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(3):1000-10.
1993: Vankelecom H; Matthys P; Van Damme J; Heremans H; Billiau A; Denef C
Immunocytochemical evidence that S-100-positive cells of the mouse anterior pituitary contain interleukin-6 immunoreactivity.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1993;41(2):151-6.
1993: Van Damme J; Proost P; Lenaerts J P; Conings R; Opdenakker G; Billiau A
Monocyte chemotactic proteins related to human MCP-1.
Advances in experimental medicine and biology 1993;351():111-8.
1992: Van Damme J; Uyttenhove C; Houssiau F; Put W; Proost P; Van Snick J
Human growth factor for murine interleukin (IL)-9 responsive T cell lines: co-induction with IL-6 in fibroblasts and identification as LIF/HILDA.
European journal of immunology 1992;22(11):2801-8.
1992: Soumillion A; Van Damme J; De Ley M
Cloning and specific polymerised-chain-reaction amplification of a third charge-separable human metallothionein isoform.
European journal of biochemistry / FEBS 1992;209(3):999-1004.
1992: Jorens P G; Van Damme J; De Backer W; Bossaert L; De Jongh R F; Herman A G; Rampart M
Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS.
Cytokine 1992;4(6):592-7.
1992: Heremans H; Dillen C; Put W; Van Damme J; Billiau A
Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels.
European journal of immunology 1992;22(9):2395-401.
1992: Fuse A; Simizu B; Van Ranst M; Opdenakker G; Van Damme J
The induction of IL-6 and gelatinase B by IL-1 in mouse cell lines transformed with bovine papillomavirus: decreased production in tumorigenic cells.
Lymphokine and cytokine research 1992;11(4):215-20.
1992: Van Damme J; Proost P; Lenaerts J P; Opdenakker G
Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family.
The Journal of experimental medicine 1992;176(1):59-65.
1992: Bernard A; Roels H; Lauwerys R; Witters R; Gielens C; Soumillion A; Van Damme J; De Ley M
Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions.
Clinica chimica acta; international journal of clinical chemistry 1992;207(3):239-49.
1992: Rampart M; Herman A G; Grillet B; Opdenakker G; Van Damme J
Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease.
Laboratory investigation; a journal of technical methods and pathology 1992;66(4):512-8.
1992: Bernard A; Roels H; Lauwerys R; Witters R; Gielens C; Soumillion A; Van Damme J; De Ley M
Protein 1 is a secretory protein of the respiratory and urogenital tracts identical to the Clara cell protein.
Clinical chemistry 1992;38(3):434-5.
1992: Schoofs L; Holman G M; Proost P; Van Damme J; Hayes T K; De Loof A
Locustakinin, a novel myotropic peptide from Locusta migratoria, isolation, primary structure and synthesis.
Regulatory peptides 1992;37(1):49-57.
1991: Opdenakker G; Masure S; Grillet B; Van Damme J
Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis.
Lymphokine and cytokine research 1991;10(4):317-24.
1991: Vandekerckhove F; Opdenakker G; Van Ranst M; Lenaerts J P; Put W; Billiau A; Van Damme J
Bradykinin induces interleukin-6 and synergizes with interleukin-1.
Lymphokine and cytokine research 1991;10(4):285-9.
1991: Van Damme J; Decock B; Bertini R; Conings R; Lenaerts J P; Put W; Opdenakker G; Mantovani A
Production and identification of natural monocyte chemotactic protein from virally infected murine fibroblasts. Relationship with the product of the mouse competence (JE) gene.
European journal of biochemistry / FEBS 1991;199(1):223-9.
1991: Opdenakker G; Masure S; Proost P; Billiau A; van Damme J
Natural human monocyte gelatinase and its inhibitor.
FEBS letters 1991;284(1):73-8.
1991: Masure S; Proost P; Van Damme J; Opdenakker G
Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8.
European journal of biochemistry / FEBS 1991;198(2):391-8.
1991: Van Ranst M; Norga K; Masure S; Proost P; Vandekerckhove F; Auwerx J; Van Damme J; Opdenakker G
The cytokine-protease connection: identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers.
Cytokine 1991;3(3):231-9.
1991: Foets B J; van den Oord J J; Billiau A; Van Damme J; Missotten L
Heterogeneous induction of major histocompatibility complex class II antigens on corneal endothelium by interferon-gamma.
Investigative ophthalmology & visual science 1991;32(2):341-5.
1991: Verwilghen J; Baroja M L; Van Vaeck F; Van Damme J; Ceuppens J L
Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Immunology 1991;72(2):269-76.
1991: Paemen L; Tips A; Schoofs L; Proost P; Van Damme J; De Loof A
Lom-AG-myotropin: a novel myotropic peptide from the male accessory glands of Locusta migratoria.
Peptides 1991;12(1):7-10.
1991: Spittaels K; Schoofs L; Grauwels L; Smet H; Van Damme J; Proost P; De Loof A
Isolation, identification and synthesis of novel oviductal motility stimulating head peptide in the Colorado potato beetle, Leptinotarsa decemlineata.
Peptides 1991;12(1):31-6.
1991: Carmeliet P; Vankelecom H; Van Damme J; Billiau A; Denef C
Release of interleukin-6 from anterior pituitary cell aggregates: developmental pattern and modulation by glucocorticoids and forskolin.
Neuroendocrinology 1991;53(1):29-34.
1991: Van Osselaer N; Van Damme J; Rampart M; Herman A G
Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
The American journal of pathology 1991;138(1):23-7.
1991: Van Damme J
Granulocyte and monocyte chemotactic factors: stimuli and producer cells.
Advances in experimental medicine and biology 1991;305():1-9.
1990: Masure S; Billiau A; Van Damme J; Opdenakker G
Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate.
Biochimica et biophysica acta 1990;1054(3):317-25.
1990: Van Damme J; Rampart M; Conings R; Decock B; Van Osselaer N; Willems J; Billiau A
The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
European journal of immunology 1990;20(9):2113-8.
1990: Anné J; Van Mellaert L; Decock B; Van Damme J; Van Aerschot A; Herdewijn P; Eyssen H
Further biological and molecular characterization of actinophage VWB.
Journal of general microbiology 1990;136(7):1365-72.
1990: Lorré K; Van Damme J; Ceuppens J L
A bidirectional regulatory network involving IL 2 and IL 4 in the alternative CD2 pathway of T cell activation.
European journal of immunology 1990;20(7):1569-75.
1990: Vankelecom H; Carmeliet P; Heremans H; Van Damme J; Dijkmans R; Billiau A; Denef C
Interferon-gamma inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures.
Endocrinology 1990;126(6):2919-26.
1990: Heremans H; Van Damme J; Dillen C; Dijkmans R; Billiau A
Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice.
The Journal of experimental medicine 1990;171(6):1853-69.
1990: Lorré K; Van Damme J; Verwilghen J; Baroja M L; Ceuppens J L
IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(12):4681-7.
1990: Kuhweide R; Van Damme J; Ceuppens J L
Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth.
European journal of immunology 1990;20(5):1019-25.
1990: Decock B; Conings R; Lenaerts J P; Billiau A; Van Damme J
Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form.
Biochemical and biophysical research communications 1990;167(3):904-9.
1990: Van Damme J; Bunning R A; Conings R; Graham R; Russell G; Opdenakker G
Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8.
Cytokine 1990;2(2):106-11.
1990: Gijbels K; Van Damme J; Proost P; Put W; Carton H; Billiau A
Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis.
European journal of immunology 1990;20(1):233-5.
1990: Kuhweide R; Van Damme J; Lorre K; Baroja M L; Tsudo M; Ceuppens J L
Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin: induction of interleukin 2-responsiveness by interleukin 6, and production of interleukin 2 by interleukin 1 [corrected]
Cytokine 1990;2(1):45-54.
1990: Broothaerts W J; van Laere A; Witters R; Préaux G; Decock B; van Damme J; Vendrig J C
Purification and N-terminal sequencing of style glycoproteins associated with self-incompatibility in Petunia hybrida.
Plant molecular biology 1990;14(1):93-102.
1990: Cabeza-Arvelaiz Y; Dillen C; Heremans H; Van Damme J; Cailleau J; Billiau A; Opdenakker G
Cholera and pertussis exotoxins protect mice against the lethal Schwartzman reaction and antagonize the effects of lipopolysaccharide on second messenger systems.
Lymphokine research 1990;9(2):125-35.
1990: Dijkmans R; Tobback M; Beuken E; Van Damme J; Billiau A
Molecular cloning of the baboon interferon-gamma cDNA.
Lymphokine research 1990;9(3):345-54.
1989: Van Damme J; Decock B; Lenaerts J P; Conings R; Bertini R; Mantovani A; Billiau A
Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine.
European journal of immunology 1989;19(12):2367-73.
1989: Rampart M; Van Damme J; Zonnekeyn L; Herman A G
Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin.
The American journal of pathology 1989;135(1):21-5.
1989: Van Damme J; Decock B; Conings R; Lenaerts J P; Opdenakker G; Billiau A
The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8.
European journal of immunology 1989;19(7):1189-94.
1989: Opdenakker G; Cabeza-Arvelaiz Y; Van Damme J
Interaction of interferon with other cytokines.
Experientia 1989;45(6):513-20.
1989: Van Damme J; Van Beeumen J; Conings R; Decock B; Billiau A
Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin.
European journal of biochemistry / FEBS 1989;181(2):337-44.
1989: Vankelecom H; Carmeliet P; Van Damme J; Billiau A; Denef C
Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system.
Neuroendocrinology 1989;49(1):102-6.
1989: Van Damme J; Schaafsma M R; Fibbe W E; Falkenburg J H; Opdenakker G; Billiau A
Simultaneous production of interleukin 6, interferon-beta and colony-stimulating activity by fibroblasts after viral and bacterial infection.
European journal of immunology 1989;19(1):163-8.
1989: Van Damme J; Schaafsma M R; Conings R; Lenaerts J P; Put W; Billiau A; Fibbe W E
Interleukin 1 induces different cytokines in human fibroblasts.
Lymphokine research 1989;8(3):289-92.
1989: Dijkmans R; Decock B; Heremans H; Van Damme J; Billiau A
Interferon-gamma is cytotoxic for normal mouse fibroblasts: enhancement by tumor necrosis factor and interleukin 1.
Lymphokine research 1989;8(1):25-34.
1988: Ceuppens J L; Baroja M L; Lorre K; Van Damme J; Billiau A
Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(11):3868-74.
1988: Baroja M L; Ceuppens J L; Van Damme J; Billiau A
Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(5):1502-7.
1988: Opdenakker G; Bosman F; Decock B; Cabeza-Arvelaiz Y; Van Damme J; Billiau A
Heterogeneity of human tissue-type plasminogen activator.
FEBS letters 1988;238(1):129-34.
1988: Van Damme J; Van Beeumen J; Opdenakker G; Billiau A
A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity.
The Journal of experimental medicine 1988;167(4):1364-76.
1988: Van Damme J; Van Beeumen J; Decock B; Van Snick J; De Ley M; Billiau A
Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(5):1534-41.
1988: Van Damme J; Van Snick J
Induction of hybridoma growth factor (HGF), identical to IL-6, in human fibroblasts by IL-1: use of HGF activity in specific and sensitive biological assays for IL-1 and IL-6.
Developments in biological standardization 1988;69():31-8.
1987: Van Damme J; Cayphas S; Van Snick J; Conings R; Put W; Lenaerts J P; Simpson R J; Billiau A
Purification and characterization of human fibroblast-derived hybridoma growth factor identical to T-cell-derived B-cell stimulatory factor-2 (interleukin-6).
European journal of biochemistry / FEBS 1987;168(3):543-50.
1987: Cayphas S; Van Damme J; Vink A; Simpson R J; Billiau A; Van Snick J
Identification of an interleukin HP1-like plasmacytoma growth factor produced by L cells in response to viral infection.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(9):2965-9.
1987: Coulie P G; Vanhecke A; Van Damme J; Cayphas S; Poupart P; De Wit L; Content J
High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.
European journal of immunology 1987;17(10):1435-40.
1987: Van Damme J; Opdenakker G; Simpson R J; Rubira M R; Cayphas S; Vink A; Billiau A; Van Snick J
Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.
The Journal of experimental medicine 1987;165(3):914-9.
1987: Van Damme J; Cayphas S; Opdenakker G; Billiau A; Van Snick J
Interleukin 1 and poly(rI).poly(rC) induce production of a hybridoma growth factor by human fibroblasts.
European journal of immunology 1987;17(1):1-7.
1985: Content J; De Wit L; Poupart P; Opdenakker G; Van Damme J; Billiau A
Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor.
European journal of biochemistry / FEBS 1985;152(2):253-7.
1985: Van Damme J; Opdenakker G; Billiau A; De Somer P; De Wit L; Poupart P; Content J
Stimulation of fibroblast interferon production by a 22K protein from human leukocytes.
The Journal of general virology 1985;66 ( Pt 4)():693-700.

Sign-in to see more